Technology & Health

New biomarker panel could accelerate autism diagnoses

Technology and Health

New biomarker panel could accelerate autism diagnoses

Investigators at the UC Davis MIND Institute and NeuroPointDX, a division of Stemina Biomarker Discovery, have identified a group of blood metabolites that could help detect some children with autism spectrum disorder (ASD). Part of the Children's Autism Metabolome Project (CAMP), the largest metabolomic ASD study ever attempted, these findings are a key step toward developing an ASD biomarker test.

Click here to read more-->
×